2025 annual financial data
Viking Therapeutics 2025 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -393,342,000 USD and net income was -359,639,000 USD.
Operating cash flow was -278,685,000 USD.
Get free Viking Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -393,342,000 USD
- Net income
- -359,639,000 USD
- Operating cash flow
- -278,685,000 USD